URGN- Urogen Pharma Ltd.

Name: Urogen Pharma Ltd. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. URGN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Barrett Elizabeth A.	153.2K	$6.99M	-
Other	Schoenberg Mark	119.8K	$5.46M	-10,000
Other	Smith Jason Drew	52.9K	$2.41M	-
Dir	Holden Stuart	20.0K	$912.0K	-
Dir	Belldegrun Arie	20.0K	$912.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 17, 2021	Henderson Molly52	Chief Financial Officer	Buy	2,500	$15.85	$39,625.00	New	-6.5%	-63.2%
May 17, 2021	Smith Jason Drew46	General Counsel	Buy	2,500	$15.71	$39,275.00	New	-6.5%	-63.2%
Apr 30, 2021	Schoenberg Mark58	Chief Medical Officer	Sale+OE	243	$20.00	$4,860.00	-1.1%	-20.4%	-63.7%
Apr 26, 2021	Schoenberg Mark58	Chief Medical Officer	Sale+OE	89	$19.63	$1,747.07	-0.4%	-26.5%	-65.1%
Jan 31, 2021	Schoenberg Mark58	Chief Medical Officer	Sale+OE	1,076	$22.07	$23,747.32	-4.9%	-	-
Jan 26, 2021	Schoenberg Mark58	Chief Medical Officer	Sale+OE	100	$22.12	$2,212.00	-0.5%	-	-
Dec 14, 2020	Barrett Elizabeth A.	Chief Executive Officer	Buy	10,000	$18.50	$185,000.00	+4.6%	-	-
Dec 4, 2020	Schoenberg Mark58	Chief Medical Officer	Sale+OE	662	$19.85	$13,140.70	-3.2%	-	-
Oct 26, 2020	Schoenberg Mark58	Chief Medical Officer	Sale+OE	101	$20.95	$2,115.56	-0.5%	-	-
Oct 15, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	2,400	$21.77	$52,247.75	-6.7%	-	-

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC